Vice President, New Product Planning

About Parabilis Medicines

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines. The company's lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin:TCF interaction, a central node in the Wnt/β-catenin pathway that has eluded drug developers for decades. Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications. Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact. For more information, visit www.parabilismed.com or follow us on LinkedIn.

What's the opportunity?

The Vice President, New Product Planning will play a key strategic leadership role in shaping the development and future direction of Parabilis Medicines' portfolio. Reporting to the Chief Business & Strategy Officer, this individual will lead New Product Planning activities across the company's pipeline, ensuring commercial, market, and strategic insights are integrated into critical program decisions throughout development.

This leader will partner cross-functionally across Clinical Development, Research, Regulatory, CMC, Business Development, and Executive Leadership to help define product and indication strategies, evaluate market opportunities, assess competitive dynamics, and inform long-term portfolio planning. The role is particularly critical as Parabilis advances zolucatetide (FOG-001) towards registrational Phase 3 study for desmoid tumor and pursue expansion indications including familial adenomatous polyposis (FAP), adamantinomatous craniopharyngioma (ACP), hepatocellular carcinoma (HCC) and a range of other Wnt/beta-catenin-driven solid tumors. The ideal candidate will bring a strong blend of commercial and marketing experience, strategic thinking, cross-functional leadership, scientific curiosity, and operational pragmatism, along with a passion for helping build innovative biotechnology companies.

Requirements

• Bachelor's degree required; MBA, PhD, PharmD, MD, or other advanced scientific/business degree preferred.
• 10+ years of experience within biotechnology or pharmaceutical industry across New Product Planning, Commercial Strategy, Portfolio Strategy, Marketing, Competitive Intelligence, or related functions.
• Extensive experience supporting late-stage development programs and contributing to commercialization or launch planning activities.
• Strong understanding of drug development and ability to integrate commercial insights into clinical and portfolio strategy discussions.
• Oncology and rare disease experience strongly preferred.
• Experience operating in innovative or first-in-class therapeutic settings where market development and indication-shaping strategies were required.
• Demonstrated ability to work effectively across highly matrixed, cross-functional organizations.
• Strong strategic thinking and analytical capabilities, with the ability to synthesize scientific, clinical, and market information into actionable business insights.
• Proven ability to influence without authority and build strong collaborative relationships across functions and organizational levels.
• Experience working closely with Global Program Team, patient advocacy organizations, and external stakeholders preferred.
• Strong communication and presentation skills, including the ability to engage senior leadership and translate complex information into clear strategic recommendations.
• Leadership mindset with the ability to operate strategically while remaining hands-on in a fast-paced, high-growth environment.
• Prior experience within oncology, precision medicine, platform biotechnology, or emerging biotechnology companies is a plus.
• Demonstrated use of AI tools in your current role and responsibilities is required. Advanced or innovative use of AI is a strong plus

Benefits

Parabilis Medicines is an equal opportunity employer and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

Contact

For more information, visit www.parabilismed.com or contact us at [insert contact information if available].

Address

Parabilis Medicines
30 Acorn Park Drive
Cambridge, MA 02140